Related Experiment Videos
Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study
Henry Völzke1, Till Ittermann, Carsten O Schmidt
1SHIP/Clinical-Epidemiological Research Unit, Institute of Community Medicine, Ernst Moritz Arndt University of Greifswald, Walther Rathenau Strasse 48, D-17487 Greifswald, Germany. voelzke@uni-greifswald.de
European Journal of Endocrinology
|July 8, 2009
Summary
Subclinical hyperthyroidism, a thyroid condition, does not appear to increase the risk of developing hypertension or affect blood pressure levels in adults. This longitudinal study found no significant association after accounting for various health factors.
Area of Science:
- Endocrinology
- Cardiovascular Health
- Epidemiology
Background:
- Subclinical hyperthyroidism is characterized by low serum thyroid-stimulating hormone (TSH) levels with normal free thyroxine (FT4) and free triiodothyronine (FT3).
- The association between subclinical hyperthyroidism and hypertension remains controversial, with limited longitudinal cohort data available.
Purpose of the Study:
- To investigate the longitudinal association between subclinical hyperthyroidism and blood pressure.
- To assess the risk of developing hypertension in individuals with subclinical hyperthyroidism.
Main Methods:
- Prospective, population-based cohort study (Study of Health in Pomerania) with 2910 participants (aged 20-79 years).
- Exclusion of subjects with elevated TSH or overt hyperthyroidism.
- Definition of subclinical hyperthyroidism: serum TSH < 0.25 mIU/l with normal FT4 and FT3 levels.
- Standardized blood pressure measurements and 5-year follow-up for hypertension incidence.
Main Results:
- Multivariable analyses revealed no statistically significant association between subclinical hyperthyroidism and blood pressure or pulse pressure in the overall population.
- While unadjusted hypertension incidence was higher in the subclinical hyperthyroidism group (31.4% vs. 19.2%), adjusted analyses showed no significant difference in hypertension risk (RR 1.23; 95% CI 0.91-1.68).
- Similar findings were observed in subgroups without prior thyroid disease or antihypertensive medication use.
Conclusions:
- Subclinical hyperthyroidism is not associated with significant changes in blood pressure or pulse pressure.
- This study found no evidence that subclinical hyperthyroidism increases the risk of developing hypertension.
Related Concept Videos
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...